Hiển thị các bài đăng có nhãn health care prices. Hiển thị tất cả bài đăng
Hiển thị các bài đăng có nhãn health care prices. Hiển thị tất cả bài đăng
Thứ Sáu, 20 tháng 6, 2014

Fourth Time is the (Anti)Charm? - UK NICE Highlights "Uncertainties in the Evidence Base" About Sovaldi

›
As we have discussed, ( here , here and here ), while anger continues to build about the $1000/ pill price sought by Gilead for its new ant...
Thứ Tư, 28 tháng 5, 2014

Sovaldi - a "Revolution" in Clinical Care, or in Marketing and Public Relations?

›
The continuing public discussion of the sky high price Gilead has set for Sovaldi (sofosbuvir,) its new antiviral drug for hepatitis C, cont...
Thứ Tư, 7 tháng 5, 2014

Some Authoritative Skepticism about the "Triumph" of Sovaldi to Add to Outrage about "Blood Money"

›
Three weeks ago we posted about the continuing controversy over the stratospheric price of the new antiviral drug for hepatitis C (HCV), sof...
Thứ Hai, 5 tháng 5, 2014

Abort, Retry, Fail? - Lancet Avoided Much Recent Unpleasantness in Reporting on New Gates Foundation CEO (Including Her Defense of $55,000 a Year for Bevacizumab)

›
The April 26, 2014 issue of the prestigious journal Lancet used two full pages and two separate articles by the same author to discuss the a...
Thứ Tư, 16 tháng 4, 2014

Knee Deep in the Hoopla - "A Triumph of Medical Technology" Sans Evidence of Superiority from Published Randomized Double Blind Controlled Trials

›
With the publication of several new articles in the prestigious New England Journal of Medicine, the buzz about Sovaldi (sofosbuvir - Gilead...
Thứ Năm, 27 tháng 3, 2014

Too Good to be True - Sovaldi Kerfuffle Focuses on Price, While Ignoring Limits of Evidence about Effectiveness and Safety

›
There seems to be rising skepticism about the prices we pay for the latest drugs, devices, and health care programs, especially in the US.  ...